C
CIN Terminal
Cannabis Investor News
A CanIDeal, Inc. Company
J
Live
Loading market data...
Expand
Symbol Name Exchange Last Change Volume Watch
Home › Markets › Loading…
BLPG Equity

BLPG

OTCMKTS · BLPG

$0.04
—
Live Price
Price History 5 Years

Analyst Coverage

Cannabis Investor News in-house rating · cin-analyst-v1.0

Neutral Conviction 1/5
48/100 composite
Fundamentals62
Regulatory49
Market40
Editorial30
Composite · trailing 12 months

Blue Line Protection earns a Neutral rating, with a 48.5 composite score and low 1/5 conviction. Fundamentals provide the clearest support at 62.0, led by exceptional gross-margin performance, positive operating profitability, positive EBITDA, and stable financial condition. The regulatory pillar contributes a middling 49.0: a balanced domestic jurisdiction posture and no enforcement hits offset weak filing cadence. The market pillar scores 40.0 because institutional pricing feeds provide no available quote, limiting confirmation from trading behavior. Editorial contributes 30.0, reflecting no qualifying newsroom or brief activity in CIN newsroom coverage. The resulting profile combines credible operating economics with insufficient market visibility, limited disclosure recency, and no editorial momentum.

Licensed fundamentals data show year-over-year revenue contracted 9.1%, keeping the revenue-growth subscore at 40.9 despite stronger profitability measures. Gross margin reached approximately 62.4%, producing the maximum 100.0 gross-margin subscore, while the 3.68% operating margin supported a 79.8 operating-margin subscore. EBITDA totaled roughly $263,238 and net income was about $88,209, reinforcing positive profitability and a 90.0 cash-runway subscore. That strength is counterbalanced by a market capitalization near $494,926, which generated no contribution from the market-cap tier. Primary regulatory filings show no dated latest filing, no regulatory events during either the latest 90-day or 180-day periods, and no enforcement hits. Those inputs translate into a 25.0 cadence subscore and an 80.0 enforcement subscore, making disclosure frequency the principal regulatory constraint rather than adverse action.

The forward catalyst sits squarely within fundamentals, the strongest pillar. Blue Line Protection already converts a high proportion of revenue into gross profit and maintains positive operating margin, EBITDA, and net income, but declining sales prevent those economics from producing a stronger composite result. Revenue stabilization would validate the durability of the 62.4% gross margin, create a firmer base for operating leverage, and raise confidence beyond the current low-conviction Neutral stance. Market confirmation also remains constrained until institutional pricing feeds restore an observable quote, while fresher primary regulatory filings would improve transparency. The single most important signal to watch is a return to positive year-over-year revenue growth without material erosion in gross margin.

Scored: 2026-10-14Valid through: 2026-11-28Weights: Fundamentals 35% · Regulatory 25% · Market 25% · Editorial 15%
Loading CIN Rating…
Fundamentals SEC & Market Data
Loading fundamentals…
Analyst Consensus
Loading analyst data…
Valuation Multiples
Loading…
Price Statistics
Loading…
Financing Activity
Loading financing data…
Insider Transactions
Loading insider data…
Regulatory Filings
Loading regulator disclosures…
Peer Comparison
Loading peer data…
Institutional DetailIR, corporate, and filing data from CIN enrichment
Corporate DetailsCompany profile
Headquarters
5576 Offices Arizona 4328 E. Magnolia Street Phoenix, AZ 85034
Phone
1-800-844-5576
CEO
Evan De***e
SEC CIK
0001416697
Website
Company website
Fundamentals & FinancialsRefreshed nightly from licensed fundamentals data
Market cap
$0.5M
Enterprise value
$1.4M
Price to book
117.96
Price to sales
0.12
EV / EBITDA
2.73
Revenue (TTM)
$4.3M
Gross profit (TTM)
$2.7M
EBITDA
$263K
Operating margin
3.7%
Profit margin
2.1%
Rev growth YoY
-9.1%
Return on equity
0.0%
Return on assets
7.0%
Shares outstanding
8.3M
Insider ownership
1.0%
Beta
1.28
Full-time employees
35
GICS sector
Industrials
GICS industry
Security & Protection Services
Filings & DisclosuresPrimary sources
Filing portal
SEC EDGAR
See something incorrect or missing?

Help us keep coverage accurate. Submit an update for CIN editorial review.

Submit an update
Complimentary Research
Would you like a deeper analysis on this company?

Request a complimentary, fully customized institutional-quality research report — tailored to your investment thesis.

Request Complimentary Report

Bullish and Bearish Analyst Opinions for BLPG (BLPG)

Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for BLPG (BLPG), a cannabis-sector equity listed on OTCMKTS. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.

CIN editorial stance: Risk Elevated. Headwinds: deep drawdown. (0 bullish signals, 2 bearish signals.)

Historical Price Data

5-year weekly price history, intraday quotes, and 52-week range for BLPG are maintained by Cannabis Investor News and refreshed throughout the trading day.